Site Search
Search Results
Increasing Access to Biomarker Testing
Specialized testing can help doctors ensure they are getting the right treatment to the right patient at the right time -- but not everyone has access. This testing, called “biomarker testing”, identifies markers or mutations in a patient’s cancer cells. The results of biomarker tests can help determine the best treatment plan for a specific patient, leading to improved survivorship and better quality of life. ...
Lamont Signs into Law Legislation to Remove Barriers to Biomarker Testing
HARTFORD – Yesterday, Gov. Ned Lamont signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease. The ...
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
... diseases like cancer. With this in mind, the volunteers asked lawmakers to improve private insurance coverage of comprehensive cutting edge biomarker testing across all communities. Last year, the legislature acted to ensure such access for Medicaid enrollees, but private insurance companies were not included. Because insurance coverage of biomarker testing has not kept pace with the speed of medical innovation, communities in Connecticut are facing significant disparities in who is ...
Legislature Prioritizing Removing Barriers to Precision Treatments
HARTFORD, CT – Legislation has been introduced, Senate Bill 307, that would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by Medicaid. Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of ...
2022 Connecticut Legislative Priorities
... Medicaid, including maintaining coverage for all 7 FDA approved quit methods. Preserving Cancer Prevention, Treatment and Survivorship Biomarker testing coverage: ACS CAN will advocate for policies that will expand appropriate coverage of biomarker testing for public and private insurance plans. Insurance coverage for biomarker testing is failing to keep pace with innovations and ...
2025 Connecticut Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved private Insurance coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
The Future of Cancer Care: The Role of Biomarkers in Advancing Personalized Medicine
... business, and others. ACS CAN will use this event to help illustrate and explore the following: How can cancer patients benefit from genetic testing and targeted therapies and what role do biomarkers serve in the development of new medicines and treatments? What long-term investments in the development of sustainable initiatives and infrastructures are necessary to facilitate biomarker discovery and development? The “real” impact these technologies will have on the quality, delivery and patient experience of care; ...
Connecticut State Lead Ambassador
... of cancer. We have worked really hard on tobacco control in our state; and that will be an ongoing fight. A victory this year was passing a biomarker testing bill for Medicaid. Going forward, we will work to pass this for private insurers. On the federal level, we are very fortunate to have the ...